Mecwins AVAC technology: a window opened on the world of proteins.

To be able to detect and quantify low-abundance proteins in biofluids for applications such as early disease diagnostics, highly sensitive detection methods are required. At Mecwins we apply the latest advancements in nanotechnology together with our in-house expertise, to help scientists and physicians reach the unreachable in the diagnostic field.

The subject of my talk will be Mecwins AVAC technology, a revolutionary digital technology able to count single protein molecules, to achieve ultra-high sensitivity, several orders of magnitude better than conventional immunoassays, remarkable throughput, multiplexing and a broad dynamic range.